Cover Image
市場調查報告書

Vakzine Projekt Management GmbH:產品平台分析

Vakzine Projekt Management GmbH - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 256040
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Vakzine Projekt Management GmbH:產品平台分析 Vakzine Projekt Management GmbH - Product Pipeline Review - 2014
出版日期: 2014年06月10日 內容資訊: 英文 24 Pages
簡介

Vakzine Projekt Management GmbH是製造疫苗及干擾素(interferon)的生物醫藥品企業。

本報告提供Vakzine Projekt Management GmbH的治療藥開發平台現狀及各開發階段的比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,彙整最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。

Vakzine Projekt Management GmbH的基本資料

Vakzine Projekt Management GmbH概要

  • 主要資訊
  • 企業資料

Vakzine Projekt Management GmbH:R&D概要

  • 主要的治療範圍

Vakzine Projekt Management GmbH:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Vakzine Projekt Management GmbH:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Vakzine Projekt Management GmbH:藥物簡介

  • VPM-1002
  • VPM-2001
  • VPM-5001

Vakzine Projekt Management GmbH:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Vakzine Projekt Management GmbH:最近的開發平台趨勢

Vakzine Projekt Management GmbH:暫停中的計劃

Vakzine Projekt Management GmbH:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC05031CDB

Global Markets Direct's, 'Vakzine Projekt Management GmbH - Product Pipeline Review - 2014', provides an overview of the Vakzine Projekt Management GmbH's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vakzine Projekt Management GmbH's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Vakzine Projekt Management GmbH including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Vakzine Projekt Management GmbH's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Vakzine Projekt Management GmbH's pipeline products

Reasons to buy

  • Evaluate Vakzine Projekt Management GmbH's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Vakzine Projekt Management GmbH in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Vakzine Projekt Management GmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Vakzine Projekt Management GmbH and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vakzine Projekt Management GmbH
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Vakzine Projekt Management GmbH and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Vakzine Projekt Management GmbH Snapshot
    • Vakzine Projekt Management GmbH Overview
    • Key Information
    • Key Facts
  • Vakzine Projekt Management GmbH - Research and Development Overview
    • Key Therapeutic Areas
  • Vakzine Projekt Management GmbH - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Vakzine Projekt Management GmbH - Pipeline Products Glance
    • Vakzine Projekt Management GmbH - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Vakzine Projekt Management GmbH - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Vakzine Projekt Management GmbH - Drug Profiles
    • VPM-1002
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VPM-2001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VPM-5001
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Vakzine Projekt Management GmbH - Pipeline Analysis
    • Vakzine Projekt Management GmbH - Pipeline Products by Target
    • Vakzine Projekt Management GmbH - Pipeline Products by Route of Administration
    • Vakzine Projekt Management GmbH - Pipeline Products by Molecule Type
    • Vakzine Projekt Management GmbH - Pipeline Products by Mechanism of Action
  • Vakzine Projekt Management GmbH - Recent Pipeline Updates
  • Vakzine Projekt Management GmbH - Dormant Projects
  • Vakzine Projekt Management GmbH - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Vakzine Projekt Management GmbH, Key Information
  • Vakzine Projekt Management GmbH, Key Facts
  • Vakzine Projekt Management GmbH - Pipeline by Indication, 2014
  • Vakzine Projekt Management GmbH - Pipeline by Stage of Development, 2014
  • Vakzine Projekt Management GmbH - Monotherapy Products in Pipeline, 2014
  • Vakzine Projekt Management GmbH - Out-Licensed Products in Pipeline, 2014
  • Vakzine Projekt Management GmbH - Out-Licensed Products/ Combination Treatment Modalities, 2014
  • Vakzine Projekt Management GmbH - Phase II, 2014
  • Vakzine Projekt Management GmbH - Preclinical, 2014
  • Vakzine Projekt Management GmbH - Pipeline by Target, 2014
  • Vakzine Projekt Management GmbH - Pipeline by Route of Administration, 2014
  • Vakzine Projekt Management GmbH - Pipeline by Molecule Type, 2014
  • Vakzine Projekt Management GmbH - Pipeline Products by Mechanism of Action, 2014
  • Vakzine Projekt Management GmbH - Recent Pipeline Updates, 2014
  • Vakzine Projekt Management GmbH - Dormant Developmental Projects,2014

List of Figures

  • Vakzine Projekt Management GmbH - Pipeline by Top 10 Indication, 2014
  • Vakzine Projekt Management GmbH - Pipeline by Stage of Development, 2014
  • Vakzine Projekt Management GmbH - Monotherapy Products in Pipeline, 2014
  • Vakzine Projekt Management GmbH - Pipeline by Top 10 Target, 2014
  • Vakzine Projekt Management GmbH - Pipeline by Top 10 Molecule Type, 2014
Back to Top